KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clorox (CLX) Operating Leases (2019 - 2025)

Historic Operating Leases for Clorox (CLX) over the last 7 years, with Q4 2025 value amounting to $341.0 million.

  • Clorox's Operating Leases rose 59.0% to $341.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $341.0 million, marking a year-over-year increase of 59.0%. This contributed to the annual value of $305.0 million for FY2025, which is 2703.35% down from last year.
  • Per Clorox's latest filing, its Operating Leases stood at $341.0 million for Q4 2025, which was up 59.0% from $286.0 million recorded in Q3 2025.
  • Clorox's Operating Leases' 5-year high stood at $418.0 million during Q2 2024, with a 5-year trough of $286.0 million in Q4 2021.
  • Over the past 5 years, Clorox's median Operating Leases value was $316.5 million (recorded in 2022), while the average stood at $328.0 million.
  • In the last 5 years, Clorox's Operating Leases soared by 1215.28% in 2023 and then tumbled by 2703.35% in 2025.
  • Over the past 5 years, Clorox's Operating Leases (Quarter) stood at $286.0 million in 2021, then grew by 11.19% to $318.0 million in 2022, then fell by 2.2% to $311.0 million in 2023, then rose by 9.0% to $339.0 million in 2024, then rose by 0.59% to $341.0 million in 2025.
  • Its Operating Leases stands at $341.0 million for Q4 2025, versus $286.0 million for Q3 2025 and $305.0 million for Q2 2025.